speb/financial-data huggingface dataset:
NERV balance_sheet (quarterly, 2025-03-31) — Total Assets: 32798326.00
NERV balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -29148843.00
NERV balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -29148843.00
NERV income_statement (quarterly, 2025-03-31) — Total Expenses: 3902884.00
NERV balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 61947169.00
NERV balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 14873480.00
NERV balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 60000000.00
NERV income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -3902884.00
NERV income_statement (quarterly, 2025-03-31) — Total Unusual Items: 149912.00
NERV income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 149912.00
NERV balance_sheet (quarterly, 2025-03-31) — Working Capital: 15977677.00
NERV income_statement (quarterly, 2025-06-30) — +Operating Expense: 3374149.00
NERV income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
NERV balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 896799.00
NERV balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 370278211.00
NERV cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 0.00
NERV cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 0.00
NERV income_statement (quarterly, 2025-06-30) — Basic Average Shares: 7568981.00
NERV income_statement (quarterly, 2025-06-30) — Basic EPS: -0.43
NERV cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 17390048.00
NERV balance_sheet (quarterly, 2025-06-30) — Capital Stock: 699.00
NERV balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 15247910.00
NERV balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 15247910.00
NERV cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2042138.00
NERV cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 256853.00
NERV cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 324836.00
NERV cash_flow (quarterly, 2025-06-30) — Change In Payable: 256853.00
NERV cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 581689.00
NERV cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 335183.00
NERV cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 916872.00
NERV cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2042138.00
NERV balance_sheet (quarterly, 2025-06-30) — Common Stock: 699.00
NERV balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -32109213.00
NERV balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 753268.00
NERV balance_sheet (quarterly, 2025-06-30) — Current Assets: 15547525.00
NERV balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2528858.00
NERV cash_flow (quarterly, 2025-06-30) — Depreciation: 1360.00
NERV cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1360.00
NERV cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1360.00
NERV income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 7568981.00
NERV income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.43
NERV income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -3258588.00
NERV income_statement (quarterly, 2025-06-30) — EBIT: -3258588.00
NERV income_statement (quarterly, 2025-06-30) — EBITDA: -3257228.00
NERV cash_flow (quarterly, 2025-06-30) — End Cash Position: 15347910.00
NERV cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
NERV cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2042138.00
NERV income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 115561.00
NERV income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2076108.00
NERV balance_sheet (quarterly, 2025-06-30) — Goodwill: 14869399.00
NERV balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 14869399.00
NERV income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
NERV income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
NERV balance_sheet (quarterly, 2025-06-30) — Invested Capital: -32109213.00
NERV cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
NERV income_statement (quarterly, 2025-06-30) — Net Income: -3258588.00
NERV income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -3258588.00
NERV income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -3258588.00
NERV income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -3258588.00
NERV income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3258588.00
NERV cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -3258588.00
NERV income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -3258588.00
NERV income_statement (quarterly, 2025-06-30) — Net Interest Income: 0.00
NERV income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 0.00
NERV balance_sheet (quarterly, 2025-06-30) — Net PPE: 2721.00
NERV balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -46978612.00
NERV income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -3372789.00
NERV income_statement (quarterly, 2025-06-30) — Normalized Income: -3374149.00
NERV cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2042138.00
NERV income_statement (quarterly, 2025-06-30) — Operating Income: -3374149.00
NERV income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
NERV balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 6993406.00
NERV balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 199615.00
NERV income_statement (quarterly, 2025-06-30) — Other Gand A: 2076108.00
NERV income_statement (quarterly, 2025-06-30) — Other Income Expense: 115561.00
NERV balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 60000000.00
NERV balance_sheet (quarterly, 2025-06-30) — Payables: 896799.00
NERV balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1650067.00
NERV balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 878791.00
NERV balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
NERV income_statement (quarterly, 2025-06-30) — Pretax Income: -3258588.00
NERV income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1360.00
NERV income_statement (quarterly, 2025-06-30) — Research And Development: 1298041.00
NERV balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 100000.00
NERV balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -402388123.00
NERV income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2076108.00
NERV balance_sheet (quarterly, 2025-06-30) — Share Issued: 6993406.00
NERV cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 298218.00
NERV balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -32109213.00
NERV balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -46978612.00
NERV income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
NERV income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
NERV balance_sheet (quarterly, 2025-06-30) — Total Assets: 30419645.00
NERV balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -32109213.00
NERV balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -32109213.00
NERV income_statement (quarterly, 2025-06-30) — Total Expenses: 3374149.00
NERV balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 62528858.00
NERV balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 14872120.00
NERV balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 60000000.00
NERV income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3374149.00
NERV income_statement (quarterly, 2025-06-30) — Total Unusual Items: 115561.00
NERV income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 115561.00
NERV balance_sheet (quarterly, 2025-06-30) — Working Capital: 13018667.00
NERV income_statement (quarterly, 2025-09-30) — +Operating Expense: 2844348.00
NERV income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
NERV balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 944492.00
NERV balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 370551108.00
NERV cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 0.00
NERV cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 0.00
NERV income_statement (quarterly, 2025-09-30) — Basic Average Shares: 7568981.00
NERV income_statement (quarterly, 2025-09-30) — Basic EPS: -0.36
NERV cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 15347910.00
NERV balance_sheet (quarterly, 2025-09-30) — Capital Stock: 699.00
NERV balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 12286646.00
NERV balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 12286646.00
NERV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2916098.00
NERV cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -72739.00
NERV cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 60255.00
NERV cash_flow (quarterly, 2025-09-30) — Change In Payable: -72739.00
NERV cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -12484.00
NERV cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -433918.00
NERV cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -446402.00
NERV cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2961264.00
NERV balance_sheet (quarterly, 2025-09-30) — Common Stock: 699.00
NERV balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -34580270.00
NERV balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 519216.00
NERV balance_sheet (quarterly, 2025-09-30) — Current Assets: 13020179.00
NERV balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2672322.00
NERV cash_flow (quarterly, 2025-09-30) — Depreciation: 1361.00
NERV cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1361.00
NERV cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1361.00
NERV income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 7568981.00
NERV income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.36
NERV income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2743954.00
NERV income_statement (quarterly, 2025-09-30) — EBIT: -2743954.00
NERV income_statement (quarterly, 2025-09-30) — EBITDA: -2742593.00
NERV cash_flow (quarterly, 2025-09-30) — End Cash Position: 12386646.00
NERV cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -45166.00
NERV cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2916098.00
NERV income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 100394.00
NERV income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1918971.00
NERV balance_sheet (quarterly, 2025-09-30) — Goodwill: 14869399.00
NERV balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 14869399.00
NERV income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
NERV income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
NERV balance_sheet (quarterly, 2025-09-30) — Invested Capital: -34580270.00
NERV cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
NERV income_statement (quarterly, 2025-09-30) — Net Income: -2743954.00
NERV income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2743954.00
NERV income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2743954.00
NERV income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2743954.00
NERV income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2743954.00
NERV cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2743954.00
NERV income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2743954.00
NERV income_statement (quarterly, 2025-09-30) — Net Interest Income: 0.00
NERV income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 0.00
NERV balance_sheet (quarterly, 2025-09-30) — Net PPE: 1360.00
NERV balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -49449669.00
NERV balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 201114.00
NERV income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2842987.00
NERV income_statement (quarterly, 2025-09-30) — Normalized Income: -2844348.00
NERV cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2916098.00
NERV income_statement (quarterly, 2025-09-30) — Operating Income: -2844348.00
NERV income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
NERV balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 6993406.00
NERV balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 633533.00
NERV income_statement (quarterly, 2025-09-30) — Other Gand A: 1918971.00
NERV income_statement (quarterly, 2025-09-30) — Other Income Expense: 100394.00
NERV balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 60000000.00
NERV balance_sheet (quarterly, 2025-09-30) — Payables: 944492.00
NERV balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1463708.00
NERV balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1208614.00
NERV balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
NERV income_statement (quarterly, 2025-09-30) — Pretax Income: -2743954.00
NERV income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1361.00
NERV income_statement (quarterly, 2025-09-30) — Research And Development: 925377.00
NERV balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 100000.00
NERV balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -405132077.00
NERV income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1918971.00
NERV balance_sheet (quarterly, 2025-09-30) — Share Issued: 6993406.00
NERV cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 272897.00
NERV balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -34580270.00
NERV balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -49449669.00
NERV income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
NERV income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
NERV balance_sheet (quarterly, 2025-09-30) — Total Assets: 28092052.00
NERV balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -34580270.00
NERV balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -34580270.00
NERV income_statement (quarterly, 2025-09-30) — Total Expenses: 2844348.00
NERV balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 62672322.00
NERV balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 15071873.00
NERV balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 60000000.00
NERV income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -2844348.00
NERV income_statement (quarterly, 2025-09-30) — Total Unusual Items: 100394.00
NERV income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 100394.00
NERV balance_sheet (quarterly, 2025-09-30) — Working Capital: 10347857.00
NERV income_statement (annual, 2025-12-31) — +Operating Expense: 15102970.00
NERV income_statement (quarterly, 2025-12-31) — +Operating Expense: 4981589.00
NERV income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
NERV income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
NERV balance_sheet (annual, 2025-12-31) — Accounts Payable: 639707.00
NERV balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 639707.00
NERV balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 548047331.00
NERV balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 548047331.00
NERV cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 0.00
NERV cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 0.00
NERV cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 0.00
NERV cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 0.00
NERV income_statement (annual, 2025-12-31) — Basic Average Shares: 8464000.00
NERV income_statement (quarterly, 2025-12-31) — Basic Average Shares: 11118000.00
NERV income_statement (annual, 2025-12-31) — Basic EPS: -34.67
NERV income_statement (quarterly, 2025-12-31) — Basic EPS: -25.51
NERV cash_flow (annual, 2025-12-31) — Beginning Cash Position: 21462008.00
NERV cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 12386646.00
NERV balance_sheet (annual, 2025-12-31) — Capital Stock: 4327.00
NERV balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4327.00
NERV balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 82301813.00
NERV balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 82301813.00
NERV balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 82301813.00
NERV balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 82301813.00
NERV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 74450741.00
NERV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 74495907.00
NERV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -13510936.00
NERV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4480740.00
NERV cash_flow (annual, 2025-12-31) — Change In Account Payable: -1059012.00
NERV cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -275228.00
NERV cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 317446.00
NERV cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -145868.00
NERV cash_flow (annual, 2025-12-31) — Change In Payable: -1059012.00
NERV cash_flow (quarterly, 2025-12-31) — Change In Payable: -275228.00
NERV cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -741566.00
NERV cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -421096.00
NERV cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 109219.00
NERV cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -64143.00
NERV cash_flow (annual, 2025-12-31) — Change In Working Capital: -632347.00
NERV cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -485239.00
NERV cash_flow (annual, 2025-12-31) — Changes In Cash: 60939805.00
NERV cash_flow (quarterly, 2025-12-31) — Changes In Cash: 70015167.00
NERV balance_sheet (annual, 2025-12-31) — Common Stock: 4327.00
NERV balance_sheet (quarterly, 2025-12-31) — Common Stock: 4327.00
NERV balance_sheet (annual, 2025-12-31) — Common Stock Equity: -140748082.00
NERV balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -140748082.00
NERV balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1650766.00
NERV balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1650766.00
NERV balance_sheet (annual, 2025-12-31) — Current Assets: 83099489.00
NERV balance_sheet (quarterly, 2025-12-31) — Current Assets: 83099489.00
NERV balance_sheet (annual, 2025-12-31) — Current Liabilities: 2290473.00
NERV balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2290473.00
NERV cash_flow (annual, 2025-12-31) — Depreciation: 5442.00
NERV cash_flow (quarterly, 2025-12-31) — Depreciation: 1360.00
NERV cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 5442.00
NERV cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1360.00
NERV cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 5442.00
NERV cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1360.00
NERV balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 171464575.00
NERV balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 171464575.00
NERV income_statement (annual, 2025-12-31) — Diluted Average Shares: 8464000.00
NERV income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 11118000.00
NERV income_statement (annual, 2025-12-31) — Diluted EPS: -34.67
NERV income_statement (quarterly, 2025-12-31) — Diluted EPS: -25.51
NERV income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -293423177.00
NERV income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -283667663.00
NERV income_statement (annual, 2025-12-31) — EBIT: -293423177.00
NERV income_statement (quarterly, 2025-12-31) — EBIT: -283667663.00
NERV income_statement (annual, 2025-12-31) — EBITDA: -293417735.00
NERV income_statement (quarterly, 2025-12-31) — EBITDA: -283666303.00
NERV cash_flow (annual, 2025-12-31) — End Cash Position: 82401813.00
NERV cash_flow (quarterly, 2025-12-31) — End Cash Position: 82401813.00
NERV cash_flow (annual, 2025-12-31) — Financing Cash Flow: 74450741.00
NERV cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 74495907.00
NERV cash_flow (annual, 2025-12-31) — Free Cash Flow: -13510936.00
NERV cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4480740.00
NERV cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 279211774.00
NERV income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 46281483.00
NERV income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 45915616.00
NERV income_statement (annual, 2025-12-31) — General And Administrative Expense: 9343497.00
NERV income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 2807972.00
NERV balance_sheet (annual, 2025-12-31) — Goodwill: 14869399.00
NERV balance_sheet (quarterly, 2025-12-31) — Goodwill: 14869399.00
NERV balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 14869399.00
NERV balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 14869399.00
NERV income_statement (annual, 2025-12-31) — Interest Expense: 0.00
NERV income_statement (quarterly, 2025-12-31) — Interest Expense: 0.00
NERV income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 0.00
NERV income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 0.00
NERV balance_sheet (annual, 2025-12-31) — Invested Capital: -140748082.00
NERV balance_sheet (quarterly, 2025-12-31) — Invested Capital: -140748082.00
NERV cash_flow (annual, 2025-12-31) — Investing Cash Flow: 0.00
NERV cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
NERV cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 80000000.00
NERV income_statement (annual, 2025-12-31) — Net Income: -293423177.00
NERV income_statement (quarterly, 2025-12-31) — Net Income: -283667663.00
NERV income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -293423177.00
NERV income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -283667663.00
NERV income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -293423177.00
NERV income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -283667663.00
NERV income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -293423177.00
NERV income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -283667663.00
NERV income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -293423177.00
NERV income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -283667663.00
NERV cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -293423177.00
NERV cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -283667663.00
NERV income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -293423177.00
NERV income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -283667663.00
NERV income_statement (annual, 2025-12-31) — Net Interest Income: -3102649.00
NERV income_statement (quarterly, 2025-12-31) — Net Interest Income: -3102649.00
NERV income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -3102649.00
NERV income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3102649.00
NERV cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -5549259.00
NERV cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -5504093.00
NERV balance_sheet (annual, 2025-12-31) — Net PPE: 0.00
NERV balance_sheet (quarterly, 2025-12-31) — Net PPE: 0.00
NERV cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 80000000.00
NERV balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -155617481.00
NERV balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -155617481.00
NERV income_statement (annual, 2025-12-31) — Normalized EBITDA: -339699218.00
NERV income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -329581919.00
NERV income_statement (annual, 2025-12-31) — Normalized Income: -339704660.00
NERV income_statement (quarterly, 2025-12-31) — Normalized Income: -329583279.00
NERV cash_flow (annual, 2025-12-31) — Operating Cash Flow: -13510936.00
NERV cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -4480740.00
NERV cash_flow (annual, 2025-12-31) — Operating Gains Losses: 279211774.00
NERV income_statement (annual, 2025-12-31) — Operating Income: -15102970.00
NERV income_statement (quarterly, 2025-12-31) — Operating Income: -4981589.00
NERV income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
NERV income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
NERV balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 43274398.00
NERV balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 43274398.00
NERV balance_sheet (annual, 2025-12-31) — Other Current Assets: 697676.00
NERV balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 697676.00
NERV income_statement (annual, 2025-12-31) — Other Gand A: 9343497.00
NERV income_statement (quarterly, 2025-12-31) — Other Gand A: 2807972.00
NERV income_statement (annual, 2025-12-31) — Other Income Expense: -275217558.00
NERV income_statement (quarterly, 2025-12-31) — Other Income Expense: -275583425.00
NERV balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 60000000.00
NERV balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 60000000.00
NERV income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -321499041.00
NERV balance_sheet (annual, 2025-12-31) — Payables: 639707.00
NERV balance_sheet (quarterly, 2025-12-31) — Payables: 639707.00
NERV balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2290473.00
NERV balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2290473.00
NERV balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
NERV balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
NERV balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 4961922.00
NERV balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 4961922.00
NERV cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 80000000.00
NERV income_statement (annual, 2025-12-31) — Pretax Income: -293423177.00
NERV income_statement (quarterly, 2025-12-31) — Pretax Income: -283667663.00
NERV income_statement (annual, 2025-12-31) — Reconciled Depreciation: 5442.00
NERV income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1360.00
NERV income_statement (annual, 2025-12-31) — Research And Development: 5759473.00
NERV income_statement (quarterly, 2025-12-31) — Research And Development: 2173617.00
NERV balance_sheet (annual, 2025-12-31) — Restricted Cash: 100000.00
NERV balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 100000.00
NERV balance_sheet (annual, 2025-12-31) — Retained Earnings: -688799740.00
NERV balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -688799740.00
NERV income_statement (annual, 2025-12-31) — Selling General And Administration: 9343497.00
NERV income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2807972.00
NERV balance_sheet (annual, 2025-12-31) — Share Issued: 43274398.00
NERV balance_sheet (quarterly, 2025-12-31) — Share Issued: 43274398.00
NERV cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1327372.00
NERV cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 459028.00
NERV balance_sheet (annual, 2025-12-31) — Stockholders Equity: -140748082.00
NERV balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -140748082.00
NERV balance_sheet (annual, 2025-12-31) — Tangible Book Value: -155617481.00
NERV balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -155617481.00
NERV income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NERV income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NERV income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
NERV income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
NERV balance_sheet (annual, 2025-12-31) — Total Assets: 97968888.00
NERV balance_sheet (quarterly, 2025-12-31) — Total Assets: 97968888.00
NERV balance_sheet (annual, 2025-12-31) — Total Capitalization: -140748082.00
NERV balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -140748082.00
NERV balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -140748082.00
NERV balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -140748082.00
NERV income_statement (annual, 2025-12-31) — Total Expenses: 15102970.00
NERV income_statement (quarterly, 2025-12-31) — Total Expenses: 4981589.00
NERV balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 238716970.00
NERV balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 238716970.00
NERV balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 14869399.00
NERV balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 14869399.00
NERV balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 236426497.00
NERV balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 236426497.00
NERV income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -15102970.00
NERV income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -4981589.00
NERV income_statement (annual, 2025-12-31) — Total Other Finance Cost: 3102649.00
NERV income_statement (annual, 2025-12-31) — Total Unusual Items: 46281483.00
NERV income_statement (quarterly, 2025-12-31) — Total Unusual Items: 45915616.00
NERV income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 46281483.00
NERV income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 45915616.00
NERV balance_sheet (annual, 2025-12-31) — Working Capital: 80809016.00
NERV balance_sheet (quarterly, 2025-12-31) — Working Capital: 80809016.00
NERV income_statement (quarterly, 2026-03-31) — +Operating Expense: 16671552.00
NERV income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
NERV balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2118225.00
NERV balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 560185880.00
NERV cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -136741.00
NERV income_statement (quarterly, 2026-03-31) — Basic Average Shares: 43900426.00
NERV income_statement (quarterly, 2026-03-31) — Basic EPS: -2.86
NERV cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 82401813.00
NERV balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4384.00
NERV balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 32659770.00
NERV balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 78064896.00
NERV cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 1079125.00
NERV cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -45294104.00
NERV cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -5427064.00
NERV cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1465073.00
NERV cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 796544.00
NERV cash_flow (quarterly, 2026-03-31) — Change In Payable: 1465073.00
NERV cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 2261617.00
NERV cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -218488.00
NERV cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2043129.00
NERV cash_flow (quarterly, 2026-03-31) — Changes In Cash: -49642043.00
NERV balance_sheet (quarterly, 2026-03-31) — Common Stock: 4384.00
NERV balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -254013860.00
NERV balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1967489.00
NERV balance_sheet (quarterly, 2026-03-31) — Current Assets: 79106779.00
NERV balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4482193.00
NERV cash_flow (quarterly, 2026-03-31) — Depreciation: 0.00
NERV cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 0.00
NERV cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 0.00
NERV balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 278596901.00
NERV income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 43900426.00
NERV income_statement (quarterly, 2026-03-31) — Diluted EPS: -2.86
NERV income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -125404384.00
NERV income_statement (quarterly, 2026-03-31) — EBIT: -16671552.00
NERV income_statement (quarterly, 2026-03-31) — EBITDA: -16671552.00
NERV cash_flow (quarterly, 2026-03-31) — End Cash Position: 32759770.00
NERV cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1079125.00
NERV cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -5427064.00
NERV cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 109360630.00
NERV income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -108732832.00
NERV income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 11416586.00
NERV balance_sheet (quarterly, 2026-03-31) — Goodwill: 14869399.00
NERV balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 14869399.00
NERV balance_sheet (quarterly, 2026-03-31) — Invested Capital: -254013860.00
NERV cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -45294104.00
NERV income_statement (quarterly, 2026-03-31) — Net Income: -125404384.00
NERV income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -125404384.00
NERV income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -125404384.00
NERV income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -125404384.00
NERV income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -125404384.00
NERV cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -125404384.00
NERV income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -125404384.00
NERV cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -45294104.00
NERV cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -120875.00
NERV balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -268883259.00
NERV balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 50978.00
NERV income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 92061280.00
NERV income_statement (quarterly, 2026-03-31) — Normalized Income: -16671552.00
NERV cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -5427064.00
NERV cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 109360630.00
NERV income_statement (quarterly, 2026-03-31) — Operating Income: -16671552.00
NERV income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
NERV balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 43841998.00
NERV balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 941883.00
NERV income_statement (quarterly, 2026-03-31) — Other Gand A: 11416586.00
NERV income_statement (quarterly, 2026-03-31) — Other Income Expense: -108732832.00
NERV balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 60000000.00
NERV balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 45405126.00
NERV balance_sheet (quarterly, 2026-03-31) — Payables: 2118225.00
NERV balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4085714.00
NERV balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 396479.00
NERV balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 4961922.00
NERV income_statement (quarterly, 2026-03-31) — Pretax Income: -125404384.00
NERV cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 1200000.00
NERV cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -45294104.00
NERV income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 0.00
NERV income_statement (quarterly, 2026-03-31) — Research And Development: 5254966.00
NERV balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 100000.00
NERV balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -814204124.00
NERV income_statement (quarterly, 2026-03-31) — Selling General And Administration: 11416586.00
NERV balance_sheet (quarterly, 2026-03-31) — Share Issued: 43841998.00
NERV cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8710302.00
NERV balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -254013860.00
NERV balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -268883259.00
NERV income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NERV income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
NERV balance_sheet (quarterly, 2026-03-31) — Total Assets: 94027156.00
NERV balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -254013860.00
NERV balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -254013860.00
NERV income_statement (quarterly, 2026-03-31) — Total Expenses: 16671552.00
NERV balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 348041016.00
NERV balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 14920377.00
NERV balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 343558823.00
NERV income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -16671552.00
NERV income_statement (quarterly, 2026-03-31) — Total Unusual Items: -108732832.00
NERV income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -108732832.00
NERV balance_sheet (quarterly, 2026-03-31) — Working Capital: 74624586.00
NES.AX income_statement (annual, 2021-06-30) — +Operating Expense: 3293919.00
NES.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 667723.00
NES.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -246009.00
NES.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 70585.00
NES.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -1155277.00
NES.AX balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 287514.00
NES.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 40853510.00
NES.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 126865.00
NES.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 126865.00
NES.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 126865.00
NES.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 4072399.00
NES.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -1155277.00
NES.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2860842.00
NES.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 56280.00
NES.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -3028631.00
NES.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 170967.00
NES.AX balance_sheet (annual, 2021-06-30) — Common Stock: 40853510.00
NES.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 5372975.00
NES.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 4454416.00
NES.AX cash_flow (annual, 2021-06-30) — Common Stock Payments: -359177.00
NES.AX balance_sheet (annual, 2021-06-30) — Current Assets: 751910.00
NES.AX balance_sheet (annual, 2021-06-30) — Current Capital Lease Obligation: 28500.00
NES.AX balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 28500.00
NES.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 824671.00
NES.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 296502.00
NES.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 296502.00
NES.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 296502.00
NES.AX income_statement (annual, 2021-06-30) — EBIT: -3097298.00
NES.AX income_statement (annual, 2021-06-30) — EBITDA: -2800796.00
NES.AX cash_flow (annual, 2021-06-30) — End Cash Position: 126865.00
NES.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: 4072399.00
NES.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: -4016119.00
NES.AX balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: 815607.00
NES.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 1612678.00
NES.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 5950759.00
NES.AX income_statement (annual, 2021-06-30) — Interest Expense: 69.00
NES.AX income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 69.00
NES.AX income_statement (annual, 2021-06-30) — Interest Income: 4701.00
NES.AX income_statement (annual, 2021-06-30) — Interest Income Non Operating: 4701.00
NES.AX cash_flow (annual, 2021-06-30) — Interest Paid Direct: -7835.00
NES.AX cash_flow (annual, 2021-06-30) — Interest Paid Supplemental Data: 7835.00
NES.AX cash_flow (annual, 2021-06-30) — Interest Received Direct: 4657.00
NES.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 5372975.00
NES.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -1155277.00
NES.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 4454416.00
NES.AX balance_sheet (annual, 2021-06-30) — Long Term Capital Lease Obligation: 259014.00
NES.AX balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 259014.00
NES.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 1357081.00
NES.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 4095239.00
NES.AX income_statement (annual, 2021-06-30) — Net Income: -3097367.00
NES.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -3097367.00
NES.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -3097367.00
NES.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -3097367.00
NES.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -3097367.00
NES.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -3097367.00
NES.AX income_statement (annual, 2021-06-30) — Net Interest Income: -3203.00
NES.AX income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: -3203.00
NES.AX cash_flow (annual, 2021-06-30) — Net Other Financing Charges: -45680.00
NES.AX balance_sheet (annual, 2021-06-30) — Net PPE: 5704750.00
NES.AX cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -1155277.00
NES.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 5372975.00
NES.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: -2800796.00
NES.AX income_statement (annual, 2021-06-30) — Normalized Income: -3097367.00
NES.AX income_statement (annual, 2021-06-30) — Operating Income: -3293919.00
NES.AX balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 197922498.00
NES.AX cash_flow (annual, 2021-06-30) — Other Cash Paymentsfrom Operating Activities: -1317390.00
NES.AX balance_sheet (annual, 2021-06-30) — Other Current Liabilities: 22.00
NES.AX balance_sheet (annual, 2021-06-30) — Other Equity Adjustments: 815607.00
NES.AX income_statement (annual, 2021-06-30) — Other Gand A: 691358.00
NES.AX income_statement (annual, 2021-06-30) — Other Income Expense: 199755.00
NES.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 199755.00
NES.AX income_statement (annual, 2021-06-30) — Other Operating Expenses: 1243232.00
NES.AX balance_sheet (annual, 2021-06-30) — Other Payable: 82330.00
NES.AX balance_sheet (annual, 2021-06-30) — Other Properties: 4593678.00
NES.AX balance_sheet (annual, 2021-06-30) — Other Receivables: 215151.00
NES.AX balance_sheet (annual, 2021-06-30) — Payables: 750053.00
NES.AX balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 750053.00
NES.AX cash_flow (annual, 2021-06-30) — Paymentsto Suppliersfor Goodsand Services: -1711241.00
NES.AX balance_sheet (annual, 2021-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 46096.00
NES.AX balance_sheet (annual, 2021-06-30) — Prepaid Assets: 409894.00
NES.AX income_statement (annual, 2021-06-30) — Pretax Income: -3097367.00
NES.AX cash_flow (annual, 2021-06-30) — Purchase Of PPE: -1155277.00
NES.AX cash_flow (annual, 2021-06-30) — Receiptsfrom Customers: 170967.00
NES.AX balance_sheet (annual, 2021-06-30) — Receivables: 215151.00
NES.AX income_statement (annual, 2021-06-30) — Reconciled Depreciation: 296502.00
NES.AX income_statement (annual, 2021-06-30) — Rent And Landing Fees: 54670.00
NES.AX cash_flow (annual, 2021-06-30) — Repurchase Of Capital Stock: -359177.00
NES.AX balance_sheet (annual, 2021-06-30) — Retained Earnings: -36296142.00
NES.AX income_statement (annual, 2021-06-30) — Salaries And Wages: 866650.00
NES.AX income_statement (annual, 2021-06-30) — Selling And Marketing Expense: 141507.00
NES.AX income_statement (annual, 2021-06-30) — Selling General And Administration: 1754185.00
NES.AX balance_sheet (annual, 2021-06-30) — Share Issued: 197922498.00
NES.AX balance_sheet (annual, 2021-06-30) — Stockholders Equity: 5372975.00
NES.AX balance_sheet (annual, 2021-06-30) — Tangible Book Value: 5372975.00
NES.AX income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
NES.AX income_statement (annual, 2021-06-30) — Tax Provision: 0.00
NES.AX income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.00
NES.AX balance_sheet (annual, 2021-06-30) — Total Assets: 6456660.00
NES.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 5372975.00
NES.AX balance_sheet (annual, 2021-06-30) — Total Debt: 287514.00
NES.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 5372975.00
NES.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 1083685.00
NES.AX balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 5704750.00
NES.AX balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 259014.00
NES.AX income_statement (annual, 2021-06-30) — Total Other Finance Cost: 7835.00
NES.AX balance_sheet (annual, 2021-06-30) — Working Capital: -72761.00
NES.AX income_statement (annual, 2022-06-30) — +Operating Expense: 2511529.00
NES.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 114167.00
NES.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -53878.00
NES.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 287163842.00
NES.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.01
NES.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 126865.00
NES.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -369840.00